Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C. (Q40009631)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

16 September 2017

Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C. (English)

1 reference

Europe PubMed Central

16 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Guo-Gang Zhang

1

1 reference

Europe PubMed Central

16 September 2017

Yong-Ping Bai

2

1 reference

Europe PubMed Central

16 September 2017

Mei-Fang Chen

3

1 reference

Europe PubMed Central

16 September 2017

Rui-Zhen Shi

4

1 reference

Europe PubMed Central

16 September 2017

De-Jian Jiang

5

1 reference

Europe PubMed Central

16 September 2017

Qiong-Mei Fu

6

1 reference

Europe PubMed Central

16 September 2017

Gui-Shan Tan

7

1 reference

Europe PubMed Central

16 September 2017

Yuan-Jian Li

8

1 reference

Europe PubMed Central

16 September 2017

publication date

26 January 2008

1 reference

Europe PubMed Central

16 September 2017

Vascular Pharmacology

1 reference

Europe PubMed Central

16 September 2017

48

1 reference

Europe PubMed Central

16 September 2017

115-121

1 reference

Europe PubMed Central

16 September 2017

2-3

1 reference

Europe PubMed Central

16 September 2017

Rosiglitazone attenuates NF-kappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1/2/p38MAPK activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Pharmacological effects of xanthones as cardiovascular protective agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Tumor necrosis factor-alpha in human arterial wall with atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

[Asymmetric dimethyl arginine (ADMA): a novel cardiovascular risk factor?]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.01.004

7 January 2021

Identifiers

10.1016/J.VPH.2008.01.004

1 reference

Europe PubMed Central

16 September 2017

1 reference

Europe PubMed Central

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40009631&oldid=1667457833"